01 1GlaxoSmithKline Inc.
01 12208503
01 1MEPOLIZUMAB
01 1POWDER FOR SOLUTION
01 12015-12-22
Patent Expiration Date : 2015-12-22
Date Granted : 2009-12-01
Brand Name : NUCALA
Patent Number : 2208503
Filing Date : 1995-12-22
Strength per Unit : 100 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2015-12-22
Date Granted : 2009-12-01
LOOKING FOR A SUPPLIER?